Related Experiment Video
Updated: Mar 19, 2026

Rapid Identification of Chemical Genetic Interactions in Saccharomyces cerevisiae
Published on: April 5, 2015
5-Fluorouracil sensitivity varies among oral micro-organisms
Eline Vanlancker1, Barbara Vanhoecke1, Rozel Smet1
1Center for Microbial Ecology and Technology (CMET), Ghent University, Coupure Links 653, 9000 Ghent, Belgium.
5-Fluorouracil (5-FU) exhibits varied effects on oral bacteria at relevant concentrations, impacting mucositis severity. This study reveals differential bacterial sensitivity to 5-FU, suggesting a role in oral dysbiosis during cancer treatment.
Area of Science:
- Microbiology
- Pharmacology
- Oral Medicine
Background:
- 5-Fluorouracil (5-FU) is a chemotherapy drug that can cause oral mucositis.
- Oral microorganisms are implicated in mucositis severity, but mechanisms are unclear.
- The antibacterial effects of 5-FU at oral cavity concentrations are unknown.
Purpose of the Study:
- To investigate the impact of physiological 5-FU concentrations on oral bacteria.
- To assess the role of dihydropyrimidine dehydrogenase (DPD) in 5-FU resistance.
Main Methods:
- Testing 5-FU concentrations (0.1-50 µM) on oral bacterial monocultures.
- Evaluating bacterial growth and viability.
- Assessing DPD activity in relation to 5-FU resistance.
Main Results:
- Oral bacteria show differential sensitivity to 5-FU.
- Some species (e.g., Klebsiella oxytoca, Streptococcus salivarius) are highly resistant.
- Other species (e.g., Lactobacillus oris, Fusobacterium nucleatum) are sensitive to low 5-FU concentrations.
- DPD was not found to be involved in 5-FU resistance.
Conclusions:
- Varied bacterial responses to 5-FU may explain oral dysbiosis and resistant organism overgrowth post-chemotherapy.
- Findings contribute to understanding 5-FU-induced oral mucositis mechanisms.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Inhibitors of Bacterial DNA Synthesis
The Oral Microbiota

